DAMPening Mortality in COVID-19: Therapeutic Insights From Basic Cardiometabolic Studies on S100A8/A9.
作者信息
Hanssen Nordin M J, Spaetgens Bart, Nagareddy Prabhakara R, Murphy Andrew J
机构信息
Diabetes Center, Department of Vascular and Internal Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands (N.M.J.H.).
Department of Internal Medicine, Division of General Internal Medicine, Section Geriatric Medicine, Maastricht University Medical Center, the Netherlands (B.S.).
出版信息
Circulation. 2021 Mar 9;143(10):971-973. doi: 10.1161/CIRCULATIONAHA.120.053025. Epub 2021 Jan 12.
Abstract
摘要
相似文献
1
DAMPening Mortality in COVID-19: Therapeutic Insights From Basic Cardiometabolic Studies on S100A8/A9.降低新冠病毒肺炎死亡率：基于S100A8/A9的基础心脏代谢研究的治疗见解
Circulation. 2021 Mar 9;143(10):971-973. doi: 10.1161/CIRCULATIONAHA.120.053025. Epub 2021 Jan 12.
2
FPR1 signaling aberrantly regulates S100A8/A9 production by CD14FCN1 macrophages and aggravates pulmonary pathology in severe COVID-19.FPR1 信号异常调控 CD14+FCN1 巨噬细胞 S100A8/A9 的产生，加重重症 COVID-19 的肺部病变。
Commun Biol. 2024 Oct 14;7(1):1321. doi: 10.1038/s42003-024-07025-4.
3
Emerging roles of neutrophil-borne S100A8/A9 in cardiovascular inflammation.中性粒细胞源性 S100A8/A9 在心血管炎症中的新兴作用。
Pharmacol Res. 2020 Nov;161:105212. doi: 10.1016/j.phrs.2020.105212. Epub 2020 Sep 28.
4
Lipocalin-2, S100A8/A9, and cystatin C: Potential predictive biomarkers of cardiovascular complications in COVID-19.载脂蛋白 2、S100A8/A9 和半胱氨酸蛋白酶抑制剂 C：COVID-19 心血管并发症的潜在预测生物标志物。
Exp Biol Med (Maywood). 2022 Jul;247(14):1205-1213. doi: 10.1177/15353702221091990. Epub 2022 Apr 23.
5
Pathogenic roles of neutrophil-derived alarmins (S100A8/A9) in heart failure: From molecular mechanisms to therapeutic insights.中性粒细胞衍生的警报素（S100A8/A9）在心力衰竭中的致病作用：从分子机制到治疗见解。
Br J Pharmacol. 2023 Mar;180(5):573-588. doi: 10.1111/bph.15998. Epub 2022 Dec 26.
6
Functional characterization of S100A8 and S100A9 in altering monolayer permeability of human umbilical endothelial cells.S100A8和S100A9在改变人脐静脉内皮细胞单层通透性方面的功能特性
PLoS One. 2014 Mar 3;9(3):e90472. doi: 10.1371/journal.pone.0090472. eCollection 2014.
7
S100A8/A9 in Inflammation.S100A8/A9 在炎症中的作用。
Front Immunol. 2018 Jun 11;9:1298. doi: 10.3389/fimmu.2018.01298. eCollection 2018.
8
S100A8/A9: From basic science to clinical application.S100A8/A9：从基础科学到临床应用。
Pharmacol Ther. 2016 Nov;167:120-131. doi: 10.1016/j.pharmthera.2016.07.015. Epub 2016 Aug 1.
9
Identification of serum proteins that bind with S100A8, S100A9 and S100A8/A9: clinical significance of using proteins for monitoring the postoperative condition of liver recipients.鉴定与 S100A8、S100A9 和 S100A8/A9 结合的血清蛋白：利用蛋白监测肝移植受者术后情况的临床意义。
Clin Chim Acta. 2010 Nov 11;411(21-22):1766-73. doi: 10.1016/j.cca.2010.07.029. Epub 2010 Jul 30.
10
S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes.S100A8/A9 在 COVID-19 发病机制中的作用：对临床结局的影响。
Cytokine Growth Factor Rev. 2022 Feb;63:90-97. doi: 10.1016/j.cytogfr.2021.10.004. Epub 2021 Oct 17.
引用本文的文献
1
S100A9 as a promising therapeutic target for diabetic foot ulcers.S100A9作为糖尿病足溃疡一个有前景的治疗靶点。
Chin Med J (Engl). 2025 Apr 20;138(8):973-981. doi: 10.1097/CM9.0000000000003543. Epub 2025 Mar 27.
2
Endogenous Ligands of TLR4 in Microglia: Potential Targets for Related Neurological Diseases.TLR4 内源性配体在小胶质细胞中的作用：相关神经疾病的潜在靶点。
Curr Drug Targets. 2024;25(14):953-970. doi: 10.2174/0113894501316051240821060249.
3
Circulating biomarkers of inflammaging as potential predictors of COVID-19 severe outcomes.衰老相关炎症的循环生物标志物可作为 COVID-19 重症结局的潜在预测指标。
Mech Ageing Dev. 2022 Jun;204:111667. doi: 10.1016/j.mad.2022.111667. Epub 2022 Mar 25.
4
Hematopoietic progenitor cell liabilities and alarmins S100A8/A9-related inflammaging associate with frailty and predict poor cardiovascular outcomes in older adults.造血祖细胞负债和警报素 S100A8/A9 相关的炎症衰老与虚弱相关，并可预测老年人不良心血管结局。
Aging Cell. 2022 Mar;21(3):e13545. doi: 10.1111/acel.13545. Epub 2022 Feb 15.
5
Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study).循环钙卫蛋白水平可预测 COVID-19 患者的严重呼吸衰竭：一项多中心前瞻性研究（CalCov 研究）
Inflamm Res. 2022 Jan;71(1):57-67. doi: 10.1007/s00011-021-01516-4. Epub 2021 Oct 30.
6
Neutrophils in cardiovascular disease: warmongers, peacemakers, or both?中性粒细胞与心血管疾病：好战分子、和平缔造者，还是二者皆是？
Cardiovasc Res. 2022 Sep 20;118(12):2596-2609. doi: 10.1093/cvr/cvab302.
7
Platelets amplify endotheliopathy in COVID-19.血小板会加剧新冠病毒肺炎中的内皮病变。
Sci Adv. 2021 Sep 10;7(37):eabh2434. doi: 10.1126/sciadv.abh2434. Epub 2021 Sep 8.
本文引用的文献
1
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.血清钙卫蛋白和异常髓系细胞亚群可区分 COVID-19 重症与轻症。
Cell. 2020 Sep 17;182(6):1401-1418.e18. doi: 10.1016/j.cell.2020.08.002. Epub 2020 Aug 5.
2
Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis.一过性间歇性高血糖通过促进髓系细胞生成加速动脉粥样硬化。
Circ Res. 2020 Sep 11;127(7):877-892. doi: 10.1161/CIRCRESAHA.120.316653. Epub 2020 Jun 22.
3
Therapeutic Vaccine Against S100A9 (S100 Calcium-Binding Protein A9) Inhibits Thrombosis Without Increasing the Risk of Bleeding in Ischemic Stroke in Mice.治疗性疫苗针对 S100A9（S100 钙结合蛋白 A9）可抑制缺血性脑卒中小鼠的血栓形成而不增加出血风险。
Hypertension. 2018 Dec;72(6):1355-1364. doi: 10.1161/HYPERTENSIONAHA.118.11316.
4
Quinoline-3-carboxamides such as tasquinimod are not specific inhibitors of S100A9.喹啉-3-甲酰胺类化合物（如他司喹莫德）并非S100A9的特异性抑制剂。
Blood Adv. 2018 May 22;2(10):1170-1171. doi: 10.1182/bloodadvances.2018016667.
5
Cellular softening mediates leukocyte demargination and trafficking, thereby increasing clinical blood counts.细胞软化介导白细胞边缘解除和运输，从而增加临床血细胞计数。
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):1987-92. doi: 10.1073/pnas.1508920113. Epub 2016 Feb 8.
Zotero 插件